Immatics N.V. (IMTX)
NASDAQ: IMTX · Real-Time Price · USD
10.25
-0.06 (-0.58%)
At close: Apr 7, 2026, 4:00 PM EDT
10.25
0.00 (0.00%)
After-hours: Apr 7, 2026, 5:37 PM EDT
Immatics Market Cap
Immatics has a market cap or net worth of $1.37 billion as of April 7, 2026. Its market cap has increased by 117.28% in one year.
Market Cap
1.37B
Enterprise Value
839.11M
1-Year Change
117.28%
Ranking
Category
Stock Price
$10.25
Market Cap Chart
Since December 12, 2018, Immatics's market cap has increased from $172.50M to $1.37B, an increase of 696.81%. That is a compound annual growth rate of 32.78%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 6, 2026 | 1.38B | -1.79% |
| Dec 31, 2025 | 1.41B | 65.88% |
| Dec 31, 2024 | 848.62M | -4.80% |
| Dec 29, 2023 | 891.43M | 34.26% |
| Dec 30, 2022 | 663.94M | -21.47% |
| Dec 31, 2021 | 845.50M | 24.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 12, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Viridian Therapeutics | 1.42B |
| Savara | 1.42B |
| AtaiBeckley | 1.40B |
| Biohaven | 1.38B |
| Bicara Therapeutics | 1.36B |
| Iovance Biotherapeutics | 1.36B |
| Monte Rosa Therapeutics | 1.35B |
| Taysha Gene Therapies | 1.34B |